Identification of lncRNA-miRNA-mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant.
Xin ZhaoDong-Yang TangXu ZuoTian-Dong ZhangCheng WangPublished in: Journal of cellular physiology (2019)
To construct a long noncoding RNA (lncRNA)-microRNA (miRNA)-messenger RNA (mRNA) regulatory network related to epithelial ovarian cancer (EOC) cisplatin-resistant, differentially expressed genes (DEGs), differentially expressed lncRNAs (DELs), and differentially expressed miRNAs (DEMs) between MDAH and TOV-112D cells lines were identified. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were conducted to analyze the biological functions of DEGs. Downstream mRNAs or upstream lncRNAs for miRNAs were analyzed at miRTarBase 7.0 or DIANA-LncBase V2, respectively. A total of 485 significant DEGs, 85 DELs, and 5 DEMs were identified. Protein-protein interaction (PPI) network of DEGs contrains 81 nodes and 141 edges was constructed, and 25 hub genes related to EOC cisplatin-resistant were identified. Subsequently, a lncRNA-miRNA-mRNA regulatory network contains 4 lncRNAs, 4 miRNAs, and 35 mRNAs was established. Taken together, our study provided evidence concerning the alteration genes involved in EOC cisplatin-resistant, which will help to unravel the mechanisms underlying drug resistant.
Keyphrases
- long noncoding rna
- genome wide identification
- genome wide analysis
- drug resistant
- transcription factor
- protein protein
- network analysis
- bioinformatics analysis
- genome wide
- small molecule
- multidrug resistant
- long non coding rna
- binding protein
- cystic fibrosis
- early stage
- cell cycle arrest
- radiation therapy
- signaling pathway
- dna methylation
- cell death
- drug induced
- oxidative stress
- pi k akt
- neoadjuvant chemotherapy
- rectal cancer
- locally advanced
- data analysis